Cyclerion Therapeutics, Inc. (CYCN) earnings

CYCN earnings moved a median of +2.03% by the close. Quarterly and annual CYCN reports and results, each read against the price at its own news timestamp. Back to the CYCN overview →

14 measured CYCN earnings events.

Where these CYCN earnings landedvs 12 measured CYCN earnings reactions
CYCN earningsMiddle 50% · -0.73% to +4.59%Zero: 0.00%Median: +2.03%Median +2.03%-6.00%0+6.00%
Middle 50% of CYCN earnings reactions-0.73% to +4.59%
Median reaction (to close)+2.03%
Measured reactions12
Point-in-time · zero look-ahead

Half of the 12 CYCN earnings events with a measured close landed between -0.73% and +4.59%; 75% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Cyclerion Therapeutics, For: Jun 30SEC filing · Form 10-Q+0.00%+1.43%
Form 10-Q Cyclerion Therapeutics, For: Mar 31SEC filing · Form 10-Q+1.46%+1.62%
Form 10-K/A Cyclerion Therapeutics, For: Dec 31SEC filing · Form 10-K+1.22%+0.61%
Form 10-K Cyclerion Therapeutics, For: Dec 31SEC filing · Form 10-K—+6.16%
Form 10-K/A Cyclerion Therapeutics, For: Dec 31SEC filing · Form 10-K+1.50%—
Form 10-Q Cyclerion Therapeutics, For: Sep 30SEC filing · Form 10-Q+1.50%—
Form 10-Q Cyclerion Therapeutics, For: Jun 30SEC filing · Form 10-Q-3.89%-11.48%
Form 10-Q Cyclerion Therapeutics, For: Mar 31SEC filing · Form 10-Q-1.48%+12.83%
Form 10-K Cyclerion Therapeutics, For: Dec 31SEC filing · Form 10-K-4.56%-7.99%
Form 10-Q Cyclerion Therapeutics, For: Sep 30SEC filing · Form 10-Q+1.70%+45.76%
Form 10-Q Cyclerion Therapeutics, For: Jun 30SEC filing · Form 10-Q—+4.07%
Form 10-Q Cyclerion Therapeutics, For: Mar 31SEC filing · Form 10-Q+0.00%+2.43%
Form 10-K Cyclerion Therapeutics, For: Dec 31SEC filing · Form 10-K—+3.70%
Form 10-Q Cyclerion Therapeutics, For: Sep 30SEC filing · Form 10-Q+0.00%-4.76%
That’s how CYCN usually reacts to earnings — get an email when it moves on news →
Keep exploring

More CYCN: analyst actions → · SEC filings → · CYCN overview →